Base-line APACHE II scores and baseline markers of protein C activation and inhibition in survivors and in nonsurvivors
. | Survivors (n = 14) . | . | Nonsurvivors (n = 18) . | . | . | ||
|---|---|---|---|---|---|---|---|
| Variable . | Mean (SD) . | Min, max . | Mean (SD) . | Min, max . | 2-sided P . | ||
| APACHE II | 19.8 (6.8) | 8, 37 | 21.7 (6.9) | 10, 34 | .41 | ||
| PC (U/mL) | 0.52 (0.23) | 0.15, 0.97 | 0.44 (0.23) | 0.16, 0.96 | .20 | ||
| F1 + 2 (nM) | 1.6 (0.6) | 0.9, 2.6 | 2.2 (1.2) | 1.1, 5.8 | .18 | ||
| APC (ng/mL) | 5.27 (2.24) | 1.54, 9.21 | 3.66 (1.64) | 0.71, 6.47 | .024 | ||
| F1 + 2-to-APC ratio | 0.57 (0.31) | 0.20, 1.20 | 1.11 (0.80) | 0.30, 2.90 | .047 | ||
. | Survivors (n = 14) . | . | Nonsurvivors (n = 18) . | . | . | ||
|---|---|---|---|---|---|---|---|
| Variable . | Mean (SD) . | Min, max . | Mean (SD) . | Min, max . | 2-sided P . | ||
| APACHE II | 19.8 (6.8) | 8, 37 | 21.7 (6.9) | 10, 34 | .41 | ||
| PC (U/mL) | 0.52 (0.23) | 0.15, 0.97 | 0.44 (0.23) | 0.16, 0.96 | .20 | ||
| F1 + 2 (nM) | 1.6 (0.6) | 0.9, 2.6 | 2.2 (1.2) | 1.1, 5.8 | .18 | ||
| APC (ng/mL) | 5.27 (2.24) | 1.54, 9.21 | 3.66 (1.64) | 0.71, 6.47 | .024 | ||
| F1 + 2-to-APC ratio | 0.57 (0.31) | 0.20, 1.20 | 1.11 (0.80) | 0.30, 2.90 | .047 | ||
Baseline APACHE II scores and baseline markers of endogenous protein C activation for survivors and nonsurvivors were compared using the Wilcoxon rank sum test. Data are summarized using means, standard deviations (SD), minimums (min), and maximums (max).